Streetbeat News

Price Targets

EMR

Emerson Electric Co (NYSE:EMR) reported weaker-than-expected sales for its third quarter, leading to a 7.7% drop in share price. Despite beating consensus estimates for net sales and adjusted EPS, the company revised its FY24 outlook slightly downward. Analysts from Oppenheimer and Wells Fargo lowered their price targets for the stock.

Portfolio Pulse from Avi Kapoor

August 08, 2024 | 1:19 pm

DIS

Wells Fargo analyst Steven Cahall maintains an Overweight rating on Walt Disney (NYSE:DIS) but lowers the price target from $136 to $116.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:19 pm

ZG

Evercore ISI Group analyst Mark Mahaney maintains an Outperform rating on Zillow Group (NASDAQ:ZG) and raises the price target from $50 to $55.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:19 pm

ZBH

Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Zimmer Biomet Holdings (NYSE:ZBH) but lowers the price target from $115 to $113.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:18 pm

WTRG

Evercore ISI Group analyst Durgesh Chopra maintains an Outperform rating on Essential Utilities (NYSE:WTRG) and raises the price target from $42 to $45.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:17 pm

WMG

Evercore ISI Group analyst Vijay Jayant maintains an Outperform rating on Warner Music Group (NASDAQ:WMG) but lowers the price target from $40 to $36.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:17 pm

WBD

Evercore ISI Group analyst Vijay Jayant maintains an Outperform rating on Warner Bros. Discovery (NASDAQ:WBD) but lowers the price target from $10 to $9.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:16 pm

IFF

Wells Fargo analyst Michael Sison maintains an Overweight rating on Intl Flavors & Fragrances (NYSE:IFF) and raises the price target from $110 to $115.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:16 pm

RVMD

Wedbush analyst Robert Driscoll has reiterated an Outperform rating on Revolution Medicines (NASDAQ:RVMD) and maintained a price target of $59.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:16 pm

WAY

Evercore ISI Group analyst Elizabeth Anderson maintains an Outperform rating on Waystar Holding (NASDAQ:WAY) and raises the price target from $25 to $27.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:15 pm